+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A commercial transplant network's perspective of value in solid organ transplantation: Strategizing for value in transplant care



A commercial transplant network's perspective of value in solid organ transplantation: Strategizing for value in transplant care



Transplantation Reviews 30(2): 71-76



Solid organ transplantation has been an area of great interest to commercial payers ever since it moved into mainstream medical care beginning in the 1980s. Over the years a system of evaluating transplant program performance based on volume and one year graft and patient survival has developed. While this system has served its purpose, there is an increasing realization from payers that a need exists for a more sophisticated way to evaluate quality and cost-effectiveness of these complex procedures. We report on the perspective of a large transplant network and its efforts to better understand the drivers of value over the entire continuum of care from referral through one year post-transplant. We evaluated members of a large commercial health plan who were referred for solid organ transplantation between January 1, 2010 and April 30, 2014. A total of 18,453 cases were evaluated for both clinical and economic outcomes. We report on two areas that can impact value over the entire continuum of care. Large variation in clinical practice and cost was noted. The observed variation was independent of inclusion in the transplant network's preferred network. The average pre-transplant and post-transplant costs for kidney, liver and heart transplantation cases at center level showed a variation of between 18 and 250% of the network's average. Clinical outcomes of median days on the waitlist, waitlist mortality and readmission within thirty days after transplant also showed wide variation. There was similar wide variation in cardiac evaluation of transplant candidates despite the existence of published recommendations. We demonstrated that pre-emptive renal transplantation is a high value strategy for this membership independent of donor source. In the studied population the data show wide variation in both clinical and economic parameters related to the transplant process in programs with statistically similar one year patient and graft survival. These results require further examination. In this era of increased concern about delivering value in medical care we may need to reassess how we evaluate organ transplantation programs.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057055361

Download citation: RISBibTeXText

PMID: 26847615

DOI: 10.1016/j.trre.2015.11.002


Related references

Rapid access to comprehensive care may explain better outcomes in persons with sepsis with solid organ transplant versus those without solid organ transplant. Clinical Infectious Diseases 60(12): 1869-1870, 2015

Effects of acute rejection vs new-onset diabetes after transplant on transplant outcomes in pediatric kidney recipients: analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database. Pediatric Transplantation 20(7): 952-957, 2016

Immune tolerance in pediatric solid organ transplant through allogeneic hematopoietic stem cell transplant and a solid organ/liver transplant from the same donor. Pediatric Transplantation 20(7): 876-877, 2016

Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database. American Journal of Kidney Diseases 56(6): 1127-1139, 2010

C4: The future of solid organ transplantation from the perspective of young transplant professionals. American Journal of Transplantation 19(6): 1867, 2019

Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET). Transplant Infectious Disease 16(2): 213-224, 2014

Post-transplantation lymphoproliferative disorders in bone marrow transplant and solid organ transplant recipients differ. Laboratory Investigation 80(3): 144A, 2000

Care of the pediatric solid organ transplant recipient. The primary care perspective. Pediatric Clinics of North America 45(6): 1395-1418, 1998

Transplantation of high-risk donor organs: a survey of US solid organ transplant center practices as reported by transplant infectious diseases physicians. Clinical Transplantation 23(6): 866-873, 2010

Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation 89(9): 1134-1140, 2010

Indications and long-term outcomes for solid organ transplant. Quality of life in solid organ transplant recipients. Medicina Intensiva 32(6): 296-303, 2008

Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clinical Infectious Diseases 48(12): 1657-1665, 2009

Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006. Journal of Clinical Microbiology 49(7): 2404-2410, 2011

Dental care and oral health in solid organ transplant recipients: a single center cross-sectional study and survey of German transplant centers. Transplant International 24(12): 1179-1188, 2011

Donor biopsy and kidney transplant outcomes: an analysis using the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) database. Transplantation 84(11): 1399-1405, 2007